Clinical Trial Update: Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line Treatment [Phase 4]

View source ↗

Summary

Ongoing Phase 4 trial evaluating the efficacy and safety of a Keverprazan-amoxicillin dual therapy as first-line treatment for Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Keverprazan

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Helicobacter Pylori | Phase 4 | Status: RECRUITING